CBCRA
Canadian Breast Cancer Research Alliance
ACRCS
Alliance canadienne pour la recherche sur le cancer du sein
:
Search:
Advanced Search

EM-800, a novel antiestrogen, acts as a pure antagonist of the transcriptional functions of estrogen receptors alpha and beta

Show simple item record

dc.contributor.author Tremblay, A. en_US
dc.contributor.author Tremblay, G. B. en_US
dc.contributor.author Labrie, C. en_US
dc.contributor.author Labrie, F. en_US
dc.contributor.author Giguere, V. en_US
dc.date.accessioned 2006-07-28T14:09:11Z
dc.date.available 2006-07-28T14:09:11Z
dc.date.issued 1998 en_US
dc.identifier.citation Endocrinology 139, 111-8 (1998) en_US
dc.identifier.uri http://hdl.handle.net/1807.1/219
dc.description This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open” below will launch the full-text article in another browser window.
dc.description.provenance Made available in DSpace on 2006-07-28T14:09:11Z (GMT). No. of bitstreams: 1 Tremblay.1998.111.html: 429 bytes, checksum: df90cdaded3240351b02b8f5a4618272 (MD5) Previous issue date: 1998 en
dc.format.extent 429 bytes
dc.format.mimetype text/html
dc.language.iso en en_US
dc.publisher Endocrine Society en_US
dc.relation.uri http://www.endojournals.org/ en_US
dc.title EM-800, a novel antiestrogen, acts as a pure antagonist of the transcriptional functions of estrogen receptors alpha and beta en_US
dc.type Article en_US

Files in this item

Files Size Description Format View
Tremblay.1998.111.html 429bytes External link HTML View/Open

This item appears in the following category

Show simple item record

Browse

Tools